JP Morgan Chase’s Quoin Pharmaceuticals QNRX Stock Holding History

JP Morgan Chase’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$33	–	7531
2025 Q1	$33	Buy	+4	New	+$53	﹤0.01%	7049
2024 Q4	–	Sell	-18	Closed	-$326	–	7675
2024 Q3	$326	Hold	18	–	–	﹤0.01%	6846
2024 Q2	$375	Hold	18	–	–	﹤0.01%	6715
2024 Q1	$612	Buy	+18	New	+$1.78K	﹤0.01%	6690
2022 Q1	–	Hold	0	–	–	–	6933
2021 Q4	–	Hold	0	–	–	–	6905
2021 Q3	–	Hold	0	–	–	–	6301

Other funds holding QNRX

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's QNRX Position: Q2 2025 in Review

JP Morgan Chase sold out of Quoin Pharmaceuticals (QNRX) in Q2 2025, closing a stake of 4 shares — an estimated $33 sold.

JP Morgan Chase first reported a position in QNRX in Q1 2024 and held it in 4 quarters. The position peaked at $612 in Q1 2024. 7 funds tracked by Wall St. Rank hold QNRX as of Q2 2025.

JP Morgan Chase reported no remaining Quoin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
JP Morgan Chase sold 4 Quoin Pharmaceuticals shares in Q2 2025, an estimated $33.
JP Morgan Chase first reported a position in Quoin Pharmaceuticals in Q1 2024 and held it in 4 quarters.
JP Morgan Chase's Quoin Pharmaceuticals position peaked at $612 in Q1 2024.
7 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.